ArticleMolecular medicine reports2016

MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection.

Wei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.